284 related articles for article (PubMed ID: 21475039)
21. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
[TBL] [Abstract][Full Text] [Related]
22. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
23. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma.
Vasiljević N; Andersson K; Bjelkenkrantz K; Kjellström C; Månsson H; Nilsson E; Landberg G; Dillner J; Forslund O
Int J Cancer; 2009 May; 124(10):2361-6. PubMed ID: 19165861
[TBL] [Abstract][Full Text] [Related]
24. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
Ho T; Horn T; Finzi E
Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
[TBL] [Abstract][Full Text] [Related]
26. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
27. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
28. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
Fernandez-Flores A
Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
[TBL] [Abstract][Full Text] [Related]
29. Keratoacanthoma: a distinct entity?
Gleich T; Chiticariu E; Huber M; Hohl D
Exp Dermatol; 2016 Feb; 25(2):85-91. PubMed ID: 26476131
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
31. The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin.
Kern WH; McCray MK
J Cutan Pathol; 1980 Oct; 7(5):318-25. PubMed ID: 7430483
[No Abstract] [Full Text] [Related]
32. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
[TBL] [Abstract][Full Text] [Related]
33. Subungual keratoacanthoma: a variant of verrucous squamous cell carcinoma of the skin.
Scarani P; Ghigi G; Bertarelli C; Eusebi V
Appl Pathol; 1983; 1(6):339-42. PubMed ID: 6679793
[TBL] [Abstract][Full Text] [Related]
34. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
Biesterfeld S; Josef J
Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
[TBL] [Abstract][Full Text] [Related]
37. EGFR and MYC gene copy number aberrations are more common in squamous cell carcinoma than keratoacanthoma: a FISH study.
Jacobs MS; Persons DL; Fraga GR
J Cutan Pathol; 2013 May; 40(5):447-54. PubMed ID: 23521519
[TBL] [Abstract][Full Text] [Related]
38. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
39. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
Cribier B; Asch P; Grosshans E
Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
[TBL] [Abstract][Full Text] [Related]
40. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
Tan KB; Lee YS
Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
